Skip to content
GovLens is in free beta — full access while we build. Join the beta →
Home
Topic

public health

171 procedures tracked

Amendment to Regulation (EC) No 1925/2006

2026/2839(RPS)

1st Reading (EP)

Treating and preventing diseases such as cancer, cardiovascular neurological diseases and measles

2025/2696(RSP)

1st Reading (EP)

Silent crisis: the mental health of Europe’s youth

2025/2552(RSP)

1st Reading (EP)

Presentation of the EU Cardiovascular Health Plan

2025/3004(RSP)

1st Reading (EP)

Public health risks in a Europe affected by global warming: tackling the spread of mosquito- and tick-borne diseases

2025/2910(RSP)

1st Reading (EP)

World Mental Health Day - addressing the socio-economic factors

2025/2907(RSP)

1st Reading (EP)

Rare Diseases

2025/2637(RSP)

1st Reading (EP)

Implementation of Europe’s Beating Cancer Plan

2025/2260(INI)

Commission Proposal

Breast cancer: the importance of screening

2025/2937(RSP)

1st Reading (EP)

Discontinuing seasonal time change

2025/2908(RSP)

1st Reading (EP)

European patients and their access to medicines

2025/2995(RSP)

1st Reading (EP)

An EU cardiovascular diseases strategy

2025/2132(INI)

Committee

Repeal of Directive 2001/83/EC

2023/0132(COD)

Committee

Summer of heatwaves in the EU: addressing the causes and providing adequate housing and health policies to address record-breaking temperatures

2025/2856(RSP)

1st Reading (EP)

The need to address urgent labour shortages and ensure quality jobs in the health care sector

2025/2529(RSP)

1st Reading (EP)

European solidarity: key to securing medicine access in a shifting geopolitical era

2026/2727(RSP)

1st Reading (EP)

Implementation of the Urban Wastewater Treatment Directive (UWWTD) and risks to the security of supply of medicines

2026/2652(RSP)

1st Reading (EP)

Menopause beyond a health issue: turning menopause into an economic, working and social priority

2026/2055(INI)

Commission Proposal

Improving mental health at work

2025/2718(RSP)

1st Reading (EP)

Amendment to Regulation (EC) No 1272/2008

2025/2660(DEA)

Commission Proposal

Amendment to Regulation (EC) No 1907/2006

2026/2822(RPS)

1st Reading (EP)

The gender health gap

2025/2795(RSP)

1st Reading (EP)

EU Preparedness Union Strategy

2025/2641(RSP)

1st Reading (EP)

The Union’s preparedness for and response to health emergencies: the case of the MV Hondius and the hantavirus warning

2026/2728(RSP)

1st Reading (EP)

Strengthening global health resilience in partner countries

2026/2731(RSP)

Committee

Ebola outbreak in the Democratic Republic of the Congo and Uganda: EU solidarity and preparedness in global health

2026/2803(RSP)

1st Reading (EP)

Women's rights and safety in the EU

2026/2056(INI)

Commission Proposal

Health care related tourism: protecting EU patients abroad

2025/2640(RSP)

1st Reading (EP)

Amendment to Regulation (EC) No 1907/2006

2025/2707(RPS)

Commission Proposal

World Day for Safety and Health at Work

2026/2692(RSP)

1st Reading (EP)

Health rules as regards animal by-products and derived products not intended for human consumption and implementing

2025/2693(RPS)

Commission Proposal

European strategy for addressing Alzheimer’s and other types of dementia

2025/2859(RSP)

1st Reading (EP)

Neurological health strategy

2026/2053(INI)

Commission Proposal

Role of EU development cooperation in combating all dimensions of child poverty in developing countries

2026/2038(INI)

Commission Proposal

Presentation of the Stockpiling Strategies - strengthening response capacities for a changing risk and threat landscape

2025/2790(RSP)

1st Reading (EP)

EU rare disease action plan

2025/2130(INL)

Committee

Amendment to Framework Decision 2004/757/JHA

2025/2929(DEA)

Commission Proposal

Organ Trafficking Control

2003/0812(CNS)

1st Reading (EP)

Air Pollution Strategies

2005/2581(RSP)

1st Reading (EP)

Bioterrorism

2005/2568(RSP)

1st Reading (EP)

Malaria Combat

2005/2531(RSP)

1st Reading (EP)

Global Influenza Pandemic Risk

2005/2530(RSP)

1st Reading (EP)

EMA Director Term

2005/0083(COD)

1st Reading (EP)

ECDC Director's Term

2005/0082(COD)

1st Reading (EP)

EU Patient Rights

2006/2665(RSP)

1st Reading (EP)

Chernobyl: Lessons Learned

2006/2561(RSP)

1st Reading (EP)

The participation of Romania in the work of the European Monitoring Centre for Drugs and Drug Addiction

2006/0087(CNS)

1st Reading (EP)

World AIDS Day

2007/2679(RSP)

1st Reading (EP)

Radioactive Contamination: Food & Feed

2007/0103(NLE)

1st Reading (EP)

Medicine Counterfeiting

2008/2653(RSP)

1st Reading (EP)

Biocides: Difenacoum Inclusion

2008/2595(RPS)

1st Reading (EP)

Campania Waste Crisis

2008/2506(RSP)

1st Reading (EP)

Medicinal products (Community procedures for the authorisation and supervision of medicinal products)

2008/0255(COD)

1st Reading (EP)

Novel Foods Procedure

2008/0002(COD)

Commission Proposal

EU Food Hygiene Experience

2009/2801(RSP)

1st Reading (EP)

Flu Epidemic

2009/2602(RSP)

1st Reading (EP)

Health Work Force

2009/2551(RSP)

1st Reading (EP)

Pharma Package & Health

2009/2506(RSP)

1st Reading (EP)

Smoke-free Environments

2009/0088(CNS)

1st Reading (EP)

Economic Governance: Lisbon Art. 9

2010/2989(RSP)

1st Reading (EP)

Tuberculosis Fight

2010/2614(RSP)

1st Reading (EP)

EU Drug Control

2010/2505(RSP)

1st Reading (EP)

Radioactive Food Contamination

2010/0098(CNS)

1st Reading (EP)

EU EHEC Outbreak

2011/2715(RSP)

1st Reading (EP)

Global Fund Usage

2011/2666(RSP)

1st Reading (EP)

Radioactivity in Drinking Water

2011/0170(NLE)

1st Reading (EP)

Certain products (amendment of Annexes II and III to Regulation (EC) No 396/2005)

2012/2730(RPS)

1st Reading (EP)

Schmallenberg Outbreak

2012/2574(RSP)

1st Reading (EP)

Homelessness & Cold Weather

2012/2545(RSP)

1st Reading (EP)

Dangerous Preparations Labelling

2012/0007(COD)

1st Reading (EP)

Child Malnutrition (Developing Countries)

2013/2992(RSP)

1st Reading (EP)

Campania: Waste Incineration Fumes

2013/2941(RSP)

1st Reading (EP)

Kaliningrad Cigarette Smuggling

2013/2877(RSP)

1st Reading (EP)

New Psychoactive Substances

2013/0305(COD)

1st Reading (EP)

Zero Tolerance: FGM

2014/2988(RSP)

1st Reading (EP)

Access to Life-Saving Medicines

2014/2831(RSP)

1st Reading (EP)

EU Alcohol Strategy

2014/2505(RSP)

1st Reading (EP)

EU Healthcare Sustainability

2015/2836(RSP)

1st Reading (EP)

Ebola of 3 march 2015

2015/2606(RSP)

1st Reading (EP)

EU Medicine Access

2015/2528(RSP)

1st Reading (EP)

Daylight Saving Time

2016/2951(RSP)

1st Reading (EP)

Glyphosate Approval Extension

2016/2787(RSP)

1st Reading (EP)

HIV/AIDS

2016/2756(RSP)

1st Reading (EP)

Drugs

2016/2561(RSP)

1st Reading (EP)

Endocrine Disruptor Criteria

2016/2536(RSP)

1st Reading (EP)

6 January 2016

2016/0802(NLE)

1st Reading (EP)

EU Vaccination Coverage

2017/2867(RSP)

1st Reading (EP)

Land of Fires Situation

2017/2583(RSP)

1st Reading (EP)

Zero Tolerance: FGM

2017/2524(RSP)

1st Reading (EP)

Control: 5F-MDMB-PINACA

2017/0346(NLE)

1st Reading (EP)

Control of Carfentanil

2017/0345(NLE)

1st Reading (EP)

Control: THF-F (Psychoactive Substance)

2017/0342(NLE)

1st Reading (EP)

Control: AB-CHMINACA

2017/0341(NLE)

1st Reading (EP)

Control: 4-fluoroisobutyrylfentanyl

2017/0339(NLE)

1st Reading (EP)

January 2018

2018/0803(NLE)

1st Reading (EP)

Lead Ammunition Ban

2019/2943(RSP)

1st Reading (EP)

Specifications for food additives listed in Annexes II and III to Regulation (EC) No 1333/2008 of the European

2020/2713(RPS)

1st Reading (EP)

Elderly Rights: COVID-19 & Beyond

2020/2703(RSP)

1st Reading (EP)

Cohesion Policy: COVID-19 Recovery

2020/2644(RSP)

1st Reading (EP)

COVID-19 Economic & Social Impacts

2020/2596(RSP)

1st Reading (EP)

Medicine Shortages

2020/2581(RSP)

1st Reading (EP)

Medicine Shortages

2020/2571(RSP)

1st Reading (EP)

COVID-19 Health & Env Response

2020/2119(INI)

1st Reading (EP)

C(2021) 8740(final) of 26 November 2021 amending the conditional marketing authorisation granted by Decision C(2020)

2021/3052(RSP)

1st Reading (EP)

COVID-19 Social Recovery

2021/2734(RSP)

1st Reading (EP)

Amending the marketing authorisation granted by Decision C(2022) 7342(final) for “Comirnaty - tozinameran, COVID-19

2022/2991(RSP)

1st Reading (EP)

Comirnaty Vaccine Authorisation

2022/2941(RSP)

1st Reading (EP)

COVID-19 EU Preparedness

2022/2735(RSP)

1st Reading (EP)

Glyphosate Approval Objection

2023/2896(RSP)

1st Reading (EP)

Gardasil 9: Marketing Objection

2023/2623(RSP)

1st Reading (EP)

Biocidal Approval: Formaldehyde (RP 3:2)

2026/2556(RSP)

1st Reading (EP)

Beating Cancer Plan

2025/2139(INI)

Committee

Obesity Prevention & Treatment

2026/2620(RSP)

1st Reading (EP)

The sale of nitrous oxide to the general public

2026/2640(RSP)

1st Reading (EP)

World Cancer Day

2026/2586(RSP)

1st Reading (EP)

EU Pet Movement (Amendment)

2026/2580(DEA)

Commission Proposal

Echinococcus multilocularis Surveillance

2026/2582(DEA)

Commission Proposal

Biotech & Life Sciences Public Health

2025/2087(INI)

1st Reading (EP)

End of Daylight Saving Time

2018/0332(COD)

Commission Proposal

Reporting Requirements (Amendment)

2023/0369(COD)

Adopted

2022 Discharge: EMCDDA

2023/2157(DEC)

Adopted

2022 Discharge: IHI JU

2023/2179(DEC)

Adopted

Mercury (Amendment)

2023/0272(COD)

Adopted

Non-communicable diseases

2023/2075(INI)

1st Reading (EP)

Mental Health

2023/2074(INI)

1st Reading (EP)

Mental Health at Work

2023/2793(RSP)

1st Reading (EP)

DEHP in Medical Devices

2023/2790(RPS)

Commission Proposal

Organic Fertilisers: End Points

2023/2721(DEA)

Commission Proposal

Antimicrobial Resistance Action

2023/2703(RSP)

1st Reading (EP)

EU Global Health Strategy

2023/2642(RSP)

1st Reading (EP)

EU Chemical Legislation & Pollutants

2023/2664(RSP)

1st Reading (EP)

Cosmetics: CMR Substances (Amendment)

2023/2621(RPS)

Commission Proposal

Antimicrobial Animal Import Ban

2023/2581(DEA)

Commission Proposal

Foods, other than those referring to the reduction of disease risk and to children's development and health

2023/2540(RPS)

Commission Proposal

Public Health

2023/2565(RSO)

1st Reading (EP)

Respiratory Infections & Drug Shortages

2023/2510(RSP)

1st Reading (EP)

ESF+

2018/0206(COD)

Adopted

Drinking Water Quality

2017/0332(COD)

Adopted

Illegal Companion Animal Trade

2019/2814(RSP)

1st Reading (EP)

Trans Fats Regulation (Amendment)

2019/2504(RPS)

1st Reading (EP)

Housing First (Homelessness)

2019/3013(RSP)

1st Reading (EP)

Poland: Sexual Education Ban

2019/2891(RSP)

1st Reading (EP)

Ebola: East Africa

2019/2897(RSP)

1st Reading (EP)

Cancer Fight

2019/2852(RSP)

1st Reading (EP)

Cancer Fight

2019/2818(RSP)

1st Reading (EP)

Plastic materials and articles intended to come into contact with food (Amendment)

2019/2707(RPS)

Commission Proposal

Cosmetic products (Amendment)

2019/2724(RPS)

Commission Proposal

EU City Clean Air Zones

2019/2738(RSP)

1st Reading (EP)

Animal Feed: Undesirable Substances

2019/2740(RPS)

Commission Proposal

Directive 2000/54/EC (Technical Amendment)

2019/2744(RPS)

Commission Proposal

Reference points for action for non-allowed pharmacologically active substances present in food of animal origin

2019/2745(RPS)

Commission Proposal

Endocrine disruptors

2019/2683(RSP)

1st Reading (EP)

Harmonised Risk Indicators (Amendment)

2019/2548(RPS)

Commission Proposal

Transitional measures for the application of public health requirements of imports of food containing both products of

2019/2540(RPS)

Commission Proposal

Cosmetic products (Amendment)

2019/2501(RPS)

Commission Proposal

2016 Discharge: EMCDDA

2017/2150(DEC)

Adopted

2016 Discharge: EMA

2017/2154(DEC)

Adopted

EU AMR Action Plan

2017/2254(INI)

1st Reading (EP)

Subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin- 4-yl]cyclopropanecarboxamide

2018/0118(NLE)

1st Reading (EP)

Control: ADB-CHMINACA

2017/0340(NLE)

Adopted

Control: CUMYL-4CN-BINACA

2017/0344(NLE)

Adopted

Subjecting the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide

2017/0152(NLE)

Adopted

Subjecting N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl) to control measures

2017/0073(NLE)

Adopted

HIV, TB & Hepatitis C

2017/2576(RSP)

1st Reading (EP)

Cosmetic products (Amendment)

2017/2627(RPS)

Commission Proposal

Methods of sampling and analysis for the control of levels of dioxins, dioxin-like PCBs and non-dioxin-like PCBs in

2016/3034(RPS)

Commission Proposal

Control of α-PVP

2015/0309(CNS)

Adopted

Medium Combustion Plant Emissions

2013/0442(COD)

Adopted

Food Information to Consumers

2008/0028(COD)

Adopted

Pharmacovigilance (Amendment)

2008/0260(COD)

Adopted

Pharmacovigilance (Amendment)

2008/0257(COD)

Adopted